Literature DB >> 20597834

Skin autofluorescence and glycemic variability.

M J Noordzij1, J D Lefrandt, R Graaff, A J Smit.   

Abstract

BACKGROUND: Accumulation of advanced glycation end products (AGEs) is accelerated during glycemic and oxidative stress and is an important predictor of complications in diabetes mellitus (DM). STUDY
DESIGN: Here we both review and present original data on the relationship between skin autofluorescence (SAF), a noninvasive measure of AGEs, and short- and intermediate-term glycemic variations.
RESULTS: Acute changes in glucose levels during an oral glucose tolerance test in 56 persons with varying degrees of glucose tolerance did not influence SAF. AGE-rich meals result in a transient postprandial rise in SAF of 10% 2-4 h later. This could not be attributed to meal-induced glycemic changes and is probably caused by the AGE content of the meal. In type 1 DM major intermediate-term improvements of glycemic control as depicted by multiple hemoglobin A1c (HbA1c) measurements were associated with lower skin AGE levels. In a well-controlled, stable type 2 DM cohort, only a weak correlation was found between SAF and HbA1c. In both studies skin AGE/SAF levels predicted complications of diabetes with an accuracy superior to that of HbA1c. SAF has also been proposed as a new tool in diagnosing impaired glucose tolerance (IGT) and DM. It proved to be more sensitive than either fasting glucose or HbA1c.
CONCLUSIONS: SAF is not influenced by short-term glycemic variations. AGE-rich meals may, however, cause a transient rise postprandially. There is a weak correlation between SAF or skin AGEs and current or time-integrated HbA1c levels. SAF has strong added value in risk prediction of complications of diabetes and is a promising tool for early detection of diabetes and IGT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20597834     DOI: 10.1089/dia.2010.0014

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  8 in total

1.  Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04       Impact factor: 8.311

Review 2.  Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.

Authors:  Alin Stirban; Lutz Heinemann
Journal:  Eur Endocrinol       Date:  2014-08-28

3.  Noninvasive skin fluorescence spectroscopy for diabetes screening.

Authors:  Alin Stirban
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

4.  Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.

Authors:  Dania L Felipe; James M Hempe; Shuqian Liu; Nate Matter; John Maynard; Carmen Linares; Stuart A Chalew
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

5.  Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.

Authors:  Marjon J Noordzij; Joop D Lefrandt; Erik A H Loeffen; Ben R Saleem; Robbert Meerwaldt; Helen L Lutgers; Andries J Smit; Clark J Zeebregts
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-19       Impact factor: 2.357

6.  Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.

Authors:  C Blanc-Bisson; F L Velayoudom-Cephise; A Cougnard-Gregoire; C Helmer; K Rajaobelina; C Delcourt; L Alexandre; L Blanco; K Mohammedi; M Monlun; V Rigalleau
Journal:  Cardiovasc Diabetol       Date:  2018-06-08       Impact factor: 9.951

Review 7.  Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.

Authors:  Bernardina T Fokkens; Andries J Smit
Journal:  Glycoconj J       Date:  2016-06-10       Impact factor: 2.916

8.  A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort).

Authors:  Saskia Corine van de Zande; Jeroen Klaas de Vries; Inge van den Akker-Scheek; Johannes Zwerver; Andries Jan Smit
Journal:  J Sport Health Sci       Date:  2020-09-26       Impact factor: 13.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.